title: Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000.
abstract: The aim of this study was to prepare and characterize solid dispersions of water insoluble non-steroidal anti-inflammatory drug, indomethacin (IND), with polyethylene glycol 4000 (PEG4000) and Gelucire 50/13 (Gelu.) for enhancing the dissolution rate of the drug. The solid dispersions (SDs) were prepared by hot melting method at 1:1, 1:2 and 1:4 drug to polymer ratios. Scanning electron microscopy (SEM), X-ray powder diffractometry (XRD) and differential scanning calorimetry (DSC) were used to examine the physical state of the drug. Furthermore, the solubility and the dissolution rate of the drug in its different systems were explored. The data from the XRD showed that the drug was still detectable in its solid state in all SDs of IND-Gelu. and disappeared in case of higher ratio of IND-PEG4000. DSC thermograms showed the significant change in melting peak of the IND when prepared as SDs suggesting the change in crystallinity of IND. The highest ratio of the polymer (1:4) enhanced the drug solubility about 4-folds or 3.5-folds in case of SDs of IND-PEG or IND-Gelu., respectively. An increased dissolution rate of IND at pH 1.2 and 7.4 was observed when the drug was dispersed in these carriers in form of physical mixtures (PMs) or SDs. IND released faster from the SDs than from the pure crystalline drug or the PMs. The dissolution rate of IND from its PMs or SDs increased with an increasing amount of polymer.
authors: Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
authors: Mahmoud
authors: M
authors: El-Badry
authors: Gihan
authors: G
authors: Fetih
authors: Mohamed
authors: M
authors: Fathy
keywords: Dissolution rate; Gelucire; Indomethacin; Solid dispersion; Solubility
references: J Pharm Sci. 1971 Sep;60(9):1281-302
references: 4935981
references: Drug Dev Ind Pharm. 2006 Feb;32(2):141-50
references: 16537195
references: Eur J Pharm Biopharm. 2005 Jan;59(1):107-18
references: 15567307
references: BMJ. 2005 Jul 30;331(7511):292-3
references: 16052024
references: Eur J Pharm Biopharm. 2000 Jul;50(1):3-12
references: 10840189
references: J Pharm Sci. 2005 May;94(5):1124-34
references: 15793806
references: J Control Release. 2003 Dec 12;93(3):355-68
references: 14644585
references: Drug Dev Ind Pharm. 2003 Mar;29(3):339-44
references: 12741614
references: Drug Dev Ind Pharm. 2007 Aug;33(8):900-6
references: 17729108
references: Drug Dev Ind Pharm. 2000 Aug;26(8):891-4
references: 10900547
references: J Pharm Pharmacol. 2007 May;59(5):645-53
references: 17524229
references: Int J Pharm. 2002 Mar 20;235(1-2):17-33
references: 11879736
references: Int J Pharm. 2002 Jan 14;231(2):131-44
references: 11755266
references: Eur J Pharm Sci. 2004 Oct;23(2):159-68
references: 15451004
references: Drug Dev Ind Pharm. 2004 Mar;30(3):303-17
references: 15109030
references: Int J Pharm. 1999 Apr 30;181(2):143-51
references: 10370210
references: Eur J Pharm Biopharm. 2007 Nov;67(3):732-42
references: 17540551
references: Pharm Dev Technol. 2007;12(1):43-53
references: 17484143
references: Pharm Dev Technol. 2005;10(4):467-77
references: 16370176
references: Eur J Pharm Biopharm. 2000 Jul;50(1):47-60
references: 10840192
references: Drug Dev Ind Pharm. 1998 Apr;24(4):389-94
references: 9876600
references: Pharm Res. 2007 Mar;24(3):521-9
references: 17252191
references: Eur J Pharm Biopharm. 2005 May;60(1):99-111
references: 15848062
references: Int J Pharm. 2004 Mar 19;272(1-2):1-10
references: 15019063
references: AAPS PharmSciTech. 2006 Feb 10;7(1):E11
references: 16584141
references: Int J Pharm. 2007 Dec 10;345(1-2):95-100
references: 17604923
references: J Pharm Sci. 1997 Jan;86(1):1-12
references: 9002452
references: Eur J Pharm Biopharm. 2007 Jan;65(1):26-38
references: 16962750
references: Pharm Acta Helv. 1978;53(11):327-32
references: 746042
references: Int J Pharm. 2004 Feb 11;270(1-2):149-66
references: 14726131
references: J Pharm Pharm Sci. 2005 Jan 12;8(1):18-25
references: 15946594